 |
CFO Summit Europe 2011 To Focus On Compliance, Governance And The Impact of Regulatory Change
MAY 17, 2011 17:49 - Article Views: 1,161
Compliance, governance and the impact of regulatory change are just some of the issues that will no doubt be on the agenda at the CFO Summit Europe 2011, which takes place from 13-15 September at The Oitavos, Cascais in Portugal. This closed-door summit, hosted by GDS International, features some of the leading voices in the European CFO sector, including Ramon Zapata, Head of Finance Operations at Novartis (NYSE:NVS); Olivier Klaric, VP Treasury at Sanofi Aventis Group (NYSE:SNY); Erik Ter Horst, CFO EMEA and VP of Finance for BT (NYSE:BT); and Clive Parrit, Vice President of the Institute of Chartered Accountants. |
 |
 |
Novartis International AG (VTX:NOVN) Rasilez®, First-in-class Direct Renin Inhibitor, Provides Greater Reduction In High Blood Pressure Than ACE Inhibitor Ramipril In Patients 65 And Older
NOV 12, 2008 02:33 - Article Views: 2,167
Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (SWF:NOVN) Rasilez HCT®, Single-pill Combination Of Rasilez® And Diuretic,
Receives Swiss Approval For The Treatment Of High Blood Pressure
OCT 29, 2008 17:19 - Article Views: 1,969
Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (SWF:NOVN) ACZ885 Phase III Data Show Rapid, Sustained Clinical Remission In
Children And Adults Suffering From A Group Of Rare, Potentially
Life-threatening Autoinflammatory Diseases
OCT 27, 2008 17:17 - Article Views: 2,117
Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (SWF:NOVN) Novartis To Acquire Nektar Therapeutics Pulmonary Business Unit,
Strengthening Respiratory Drug Delivery Capabilities
OCT 21, 2008 16:17 - Article Views: 871
Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (SWF:NOVN) Novartis Delivers Sustained Strong Performance In First Nine Months
Of 2008 Underpinned By Accelerating Growth In Pharmaceuticals
OCT 20, 2008 15:03 - Article Views: 2,665
Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (SWF:NOVN) Early Data Show Potential For Imatinib To Treat Life-threatening Form
Of Pulmonary Artery Disease
OCT 8, 2008 15:17 - Article Views: 3,189
Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (SWF:NOVN) New Phase II Data On NVA237, A Novel Once-daily Treatment For COPD,
show Promising Efficacy And Tolerability With Potentially Faster
Onset Than Tiotropium
OCT 7, 2008 15:17 - Article Views: 1,204
Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (SWF:NOVN) New Study Shows Potential Benefits Of Innovative Xolair® Anti-ige
Therapy In Treating Children Suffering From Moderate-to-severe
Allergic Asthma
OCT 6, 2008 15:17 - Article Views: 444
Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
